Both in Biotechnology
Inhibikase Therapeutics vs Alector
Over the past year IKT returned 0.0% and ALEC returned +56.9%; their daily moves had a correlation of 0.28.
IKT 0.0% ALEC +56.9%Growth of $1, one year, split-adjusted
| Metric | IKT | ALEC |
|---|---|---|
| Price | $1.48 | $2.05 |
| Market cap | $206.5M | $228.9M |
| Today | −3.90% | −4.65% |
| 1 month | −26.0% | +3.0% |
| 6 months | −23.3% | −20.2% |
| Year to date | −27.8% | +31.4% |
| 1 year | +0.7% | +39.5% |
| Revenue growth (YoY) | — | −57.8% |
| Gross margin | — | 100.0% |
| Net margin | — | −692.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 16.5× |
| Net cash | $159.0M | $162.9M |
| Dividend yield | — | — |
| Volatility (60d) | 50.9% | 93.3% |
| Short % of float | 17.8% | 11.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).